Home LiteratureArticle Details
PMID: 20501937 Published · epublish English Journal Article Research Support, N.I.H., Extramural

Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.

Science signaling ·Vol. 3 ·No. 123 ·2010-05-25 ·Pages ra41

Razani B, Zarnegar B, Ytterberg AJ, Shiba T, Dempsey PW, Ware CF, Loo JA, Cheng G

Abstract

Canonical and noncanonical nuclear factor kappaB (NF-kappaB) signaling are the two basic pathways responsible for the release of NF-kappaB dimers from their inhibitors. Enhanced NF-kappaB signaling leads to inflammatory and proliferative diseases; thus, inhibitory pathways that limit its activity are critical. Whereas multiple negative feedback mechanisms control canonical NF-kappaB signaling, none has been identified for the noncanonical pathway. Here, we describe a mechanism of negative feedback control of noncanonical NF-kappaB signaling that attenuated the stabilization of NF-kappaB-inducing kinase (NIK), the central regulatory kinase of the noncanonical pathway, induced by B cell-activating factor receptor (BAFF-R) and lymphotoxin beta receptor (LTbetaR). Inhibitor of kappaB (IkappaB) kinase alpha (IKKalpha) was previously thought to lie downstream of NIK in the noncanonical NF-kappaB pathway; we showed that phosphorylation of NIK by IKKalpha destabilized NIK. In the absence of IKKalpha-mediated negative feedback, the abundance of NIK increased after receptor ligation. A form of NIK with mutations in the IKKalpha-targeted serine residues was more stable than wild-type NIK and resulted in increased noncanonical NF-kappaB signaling. Thus, in addition to the regulation of the basal abundance of NIK in unstimulated cells by a complex containing tumor necrosis factor receptor-associated factor (TRAF) and cellular inhibitor of apoptosis (cIAP) proteins, IKKalpha-dependent destabilization of NIK prevents the uncontrolled activity of the noncanonical NF-kappaB pathway after receptor ligation.

MeSH Terms
Animals B-Cell Activation Factor Receptor/metabolism Blotting, Western Cell Line Cells, Cultured Feedback, Physiological/physiology Fibroblasts/cytology,metabolism Humans I-kappa B Kinase/genetics,metabolism Immunoprecipitation Inhibitor of Apoptosis Proteins/metabolism Lymphotoxin beta Receptor/metabolism Mice Mutation NF-kappa B/genetics,metabolism Phosphorylation Protein Binding Protein Serine-Threonine Kinases/genetics,metabolism RNA Interference Serine/genetics,metabolism Signal Transduction/physiology TNF Receptor-Associated Factor 2/genetics,metabolism TNF Receptor-Associated Factor 3/genetics,metabolism Transfection
Chemicals
B-Cell Activation Factor Receptor Inhibitor of Apoptosis Proteins Lymphotoxin beta Receptor NF-kappa B TNF Receptor-Associated Factor 2 TNF Receptor-Associated Factor 3 Serine Protein Serine-Threonine Kinases I-kappa B Kinase NF-kappa B kinase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Razani Bahram
Department of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, 609 Charles E. Young Drive East, Los Angeles, CA 90095, USA.
Zarnegar Brian
Ytterberg A Jimmy
Shiba Travis
Dempsey Paul W
Ware Carl F
Loo Joseph A
Cheng Genhong
References (41)
41 references, click to expand
  1. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Cancer Cell. 2007 Aug;12(2):131-44 PMID: 17692805
  2. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.
    J Biol Chem. 2003 Dec 19;278(51):51134-42 PMID: 14532284
  3. The two NF-kappaB activation pathways and their role in innate and adaptive immunity.
    Trends Immunol. 2004 Jun;25(6):280-8 PMID: 15145317
  4. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
    Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10883-8 PMID: 18663224
  5. Ubiquitin-independent degradation of proteins by the proteasome.
    Biochim Biophys Acta. 2008 Dec;1786(2):153-77 PMID: 18558098
  6. NF-kappaB and the immune response.
    Oncogene. 2006 Oct 30;25(51):6758-80 PMID: 17072327
  7. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.
    Nature. 2002 Mar 14;416(6877):190-4 PMID: 11894097
  8. The NF-kappaB-independent functions of IKK subunits in immunity and cancer.
    Trends Cell Biol. 2009 Aug;19(8):404-13 PMID: 19648011
  9. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.
    EMBO J. 2001 Dec 3;20(23):6805-15 PMID: 11726516
  10. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Arthritis Rheum. 2001 Jun;44(6):1313-9 PMID: 11407690
  11. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
    Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3503-8 PMID: 18292232
  12. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.
    Immunity. 2004 Oct;21(4):477-89 PMID: 15485626
  13. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Cancer Cell. 2007 Aug;12(2):115-30 PMID: 17692804
  14. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
    J Exp Med. 2006 Oct 30;203(11):2413-8 PMID: 17015635
  15. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    J Exp Med. 2001 Mar 5;193(5):631-6 PMID: 11238593
  16. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
    Nat Immunol. 2008 Dec;9(12):1371-8 PMID: 18997794
  17. NF-kappa B: ten years after.
    Cell. 1996 Oct 4;87(1):13-20 PMID: 8858144
  18. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
    Science. 2001 Aug 24;293(5534):1495-9 PMID: 11520989
  19. Frequent inactivation of A20 in B-cell lymphomas.
    Nature. 2009 Jun 4;459(7247):712-6 PMID: 19412163
  20. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.
    J Immunol. 2001 Jan 1;166(1):6-10 PMID: 11123269
  21. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
    Nature. 1997 Aug 7;388(6642):548-54 PMID: 9252186
  22. The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.
    Oncogene. 2004 Mar 15;23(11):2028-36 PMID: 15021890
  23. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
    Oncogene. 2006 Oct 30;25(51):6685-705 PMID: 17072322
  24. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.
    Mol Cell Biol. 2000 Feb;20(4):1170-8 PMID: 10648602
  25. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
    Immunity. 2008 Mar;28(3):391-401 PMID: 18313334
  26. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
    Nature. 2009 Jun 4;459(7247):717-21 PMID: 19412164
  27. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Nat Immunol. 2008 Dec;9(12):1364-70 PMID: 18997792
  28. Protein profiling of plastoglobules in chloroplasts and chromoplasts. A surprising site for differential accumulation of metabolic enzymes.
    Plant Physiol. 2006 Mar;140(3):984-97 PMID: 16461379
  29. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.
    J Biol Chem. 2004 Jul 16;279(29):30099-105 PMID: 15140882
  30. NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis.
    J Clin Invest. 2005 Jul;115(7):1848-54 PMID: 15937549
  31. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    J Biol Chem. 2004 Jun 18;279(25):26243-50 PMID: 15084608
  32. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
    Immunity. 2006 Sep;25(3):403-15 PMID: 16973390
  33. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.
    Nat Immunol. 2002 Oct;3(10):958-65 PMID: 12352969
  34. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
    J Exp Med. 2003 Sep 1;198(5):771-81 PMID: 12939342
  35. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry.
    J Mass Spectrom. 1999 Feb;34(2):105-16 PMID: 10093212
  36. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.
    Immunity. 2007 Aug;27(2):253-67 PMID: 17723217
  37. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
    J Clin Invest. 2002 Jan;109(1):59-68 PMID: 11781351
  38. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.
    J Biol Chem. 2005 Dec 9;280(49):40578-82 PMID: 16223731
  39. IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing.
    Mol Cell. 2007 Jul 20;27(2):214-27 PMID: 17643371
  40. Ubiquitin-dependent protein degradation.
    Annu Rev Genet. 1996;30:405-39 PMID: 8982460
  41. RelB cellular regulation and transcriptional activity are regulated by p100.
    J Biol Chem. 2002 Jan 11;277(2):1405-18 PMID: 11687592
Article Info
Journal
Science signaling
Abbr.
Sci Signal
ISSN
1937-9145
Published
2010-05-25
Epub
2010-00-25
Pages
ra41
Language
English
Region
United States
NLM ID
101465400
PMCID
PMC2913610
Subset
IM
Grants
NIAID NIH HHS · R01 AI033068-10 · United States
NIGMS NIH HHS · R01 GM078607 · United States
NHLBI NIH HHS · F30 HL095309-02 · United States
NIAID NIH HHS · R01 AI069120 · United States
NCI NIH HHS · CA69381 · United States
NCI NIH HHS · P01 CA069381-140001 · United States
NHLBI NIH HHS · F30 HL095309 · United States
NIAID NIH HHS · R01 AI033068 · United States
NCI NIH HHS · P01 CA069381 · United States
NIGMS NIH HHS · T32 GM008042 · United States
NIAID NIH HHS · R21 AI092525 · United States
NIAID NIH HHS · AI33068 · United States
NIGMS NIH HHS · R01 GM078607-04 · United States
NIAID NIH HHS · R01 AI069120-05 · United States
NIAID NIH HHS · R37 AI033068 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com